Improving lung cancer screening for patients and providers
A Multilevel Intervention to Address Health Disparities in Lung Cancer Screening
This study is testing a new way to improve communication about lung cancer screening between doctors and patients, especially for African Americans, to see if it helps more people get screened.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 368 (estimated) |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Sponsor | Georgetown University Academic / other |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Trial ID | NCT04675476 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of a multilevel intervention designed to enhance communication and knowledge between healthcare providers and patients regarding lung cancer screening. It focuses on addressing health disparities in screening awareness and utilization, particularly among African American populations compared to whites. The intervention will be implemented in four primary care clinics within the MedStar Health system, utilizing a quasi-experimental design with pretest-posttest assessments and a nonequivalent control group.
Who should consider this trial
Good fit: Ideal candidates for this study are English-speaking individuals aged 50-80 who are current or recent smokers with a significant smoking history and have not adhered to lung cancer screening guidelines.
Not a fit: Patients with a history of lung cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly increase lung cancer screening rates among underserved populations, leading to earlier detection and improved outcomes.
How similar studies have performed: Other studies have shown success in improving health outcomes through targeted interventions addressing health disparities, suggesting a promising approach in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 50-80 years old; * current cigarette smoker or quit within 15 years; * a 20+ pack-year smoking history; * non-adherent to lung screening (\>13 months); * English-speaking; * scheduled for an upcoming clinic appointment (4 weeks - 8 weeks); and * able and willing to provide meaningful consent and complete telephone interviews Exclusion Criteria: * Individuals with a history of lung cancer
Where this trial is running
Washington D.C., District of Columbia
- MedStar Health — Washington D.C., District of Columbia, United States (Recruiting)
Study contacts
- Study coordinator: Randi M Williams, PhD
- Email: rmw27@georgetown.edu
- Phone: (202) 687-7036
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.